Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: A randomized, double-blind, placebo-controlled trial

TY - JOUR

T1 - Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes

T2 - A randomized, double-blind, placebo-controlled trial

AU - Lynch, Mary E.

AU - Clark, Alexander J.

AU - Sawynok, Jana

AU - Sullivan, Michael J.L.

N1 - Funding Information: Received from the Departments of Psychiatry and Anesthesiology, Dalhousie University, Halifax, Nova Scotia, Canada. Submitted for publication October 6, 2004. Accepted for publication March 15, 2005. Supported by Epicept Corporation, Englewood Cliffs, New Jersey. Presented in a workshop at the joint meeting of the Canadian and American Pain Societies in Vancouver, British Columbia, Canada, May 8, 2004. Dr. Sawynok holds a patent for topical antidepressants (other than amitriptyline) as analgesics (US patent No. 6,211,171).

PY - 2005/7

Y1 - 2005/7

UR - http://www.scopus.com/inward/record.url?scp=21744437460&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21744437460&partnerID=8YFLogxK

U2 - 10.1097/00000542-200507000-00021

DO - 10.1097/00000542-200507000-00021

M3 - Article

AN - SCOPUS:21744437460

SN - 0003-3022

VL - 103

SP - 140

EP - 146

JO - Anesthesiology

JF - Anesthesiology

IS - 1

ER -